April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Rate of Intraocular Pressure Spikes in Open Angle Glaucoma Patients Undergoing Phacoemulsification Using Difluprednate Ophthalmic Emulsion 0.05 Postoperatively Bid or Qd
Author Affiliations & Notes
  • Melissa M. Cable
    Discover Vision Centers, Independence, Missouri
  • Footnotes
    Commercial Relationships  Melissa M. Cable, alcon (C), bausch and lomb (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4322. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Melissa M. Cable; Rate of Intraocular Pressure Spikes in Open Angle Glaucoma Patients Undergoing Phacoemulsification Using Difluprednate Ophthalmic Emulsion 0.05 Postoperatively Bid or Qd. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4322.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report rates and timing of intraocular pressure spikes in open angle glaucoma patients undergoing uncomplicated phacoemulsification by one surgeon using difluprednate ophthalmic emulsion 0.05% bid or qd postoperatively.

Methods: : Retrospective chart review of 200 consecutive uncomplicated patients previously diagnosed with open angle glaucoma.

Results: : Of 200 consecutive phacoemulsification patients 14 were identified by electronic medical records as open angle glaucoma. Of the 14, 7 or 50% responded with intraocular pressure spikes of 10 mm Hg or more within the first postoperative week. None had a history of previous steroid response. 4 patients in the bid group and 3 patients in the qd group experienced intraocular pressure spikes. All spikes occurred on pod1 except one spike in the qd group which occurred on pod7.

Conclusions: : Steroid response occurs in 4-8% of the general population and up to 95% in open angle glaucoma patients when exposed to steroid for up to 6 weeks. Difluprednate is a strong topical steroid. It may cause early and significant elevations of intraocular pressure when used postoperatively. Intraocular pressure elevations may be more likely in open angle glaucoma patients using difluprednate even if they are not known steroid responders.

Keywords: corticosteroids • treatment outcomes of cataract surgery • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×